Which companies are leading the pack in terms of market share of the sequencing sector? Michael Eisenstein reports.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Transverse dielectrophoretic-based DNA nanoscale confinement
Scientific Reports Open Access 13 April 2018
-
Next generation sequencing reads comparison with an alignment-free distance
BMC Research Notes Open Access 03 December 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Rohde, H. et al. N. Engl. J. Med. 365, 718–724 (2011).
Loman, N.J. et al. Nat. Biotechnol. 30, 434–439 (2012).
Koren, S. et al. Nat. Biotechnol. 30, 693–700 (2012).
Peters, B.A. et al. Nature 487, 190–195 (2012).
Quail, M. et al. BMC Genomics 13, 341 (2012).
Lam, H.Y. et al. Nat. Biotechnol. 30, 78–82 (2011).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eisenstein, M. The battle for sequencing supremacy. Nat Biotechnol 30, 1023–1026 (2012). https://doi.org/10.1038/nbt.2412
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2412
This article is cited by
-
Illumina swallows PacBio in long shot for market domination
Nature Biotechnology (2019)
-
Transverse dielectrophoretic-based DNA nanoscale confinement
Scientific Reports (2018)
-
Next generation sequencing reads comparison with an alignment-free distance
BMC Research Notes (2014)